BioToolsInnovator Cohort

LOS ANGELES – May 29, 2024 – BioTools Innovator, the first accelerator dedicated to supporting life science tools and diagnostics startups, announced today that 20 companies have been selected to participate in its annual BioTools Innovator Accelerator, a four-month program providing in-depth, customized mentorship from senior industry leaders, funding opportunities, and engagement with peers and advisors.

The 2024 cohort was chosen by the BioTools Innovator selection committee including the senior leadership teams of the program’s corporate partners, Research Corporation Technologies (RCT), BroadOak Capital Partners, and Nissan Chemical America Corporation, with input from more than 130 industry judges from leading life science firms.

The top 20 companies were selected to participate from a pool of more than 300 applicants from 33 countries and 35 U.S. states. The BioTools Innovator 2024 Cohort will attend the program’s kick off, joining the MedTech Innovator U.S. and Asia Pacific cohorts at the invitation-only Innovator Summit 2024 on June 12 -13. This event connects the leadership teams from the latest cohorts with MTI’s partners, alumni, and other industry leaders.

​“Now in its fourth year, BioTools Innovator’s mission is to nurture the life science entrepreneurs whose technologies enable more efficient drug discovery and development processes, and faster and more accurate diagnostics,” said Kathryn Zavala, managing director of BioTools Innovator. “With the expertise and guidance of distinguished thought leaders in the biotools and diagnostics industries, our innovators are better positioned to meaningfully contribute to the advancement of human health.”

The 20 companies awarded a spot in the BioTools Innovator 2024 Accelerator are:

Anvil Diagnostics – Cambridge, Massachusetts

Autolomous – London

Axolotl Biosciences – Victoria, British Columbia

CellRev – Newcastle Upon Tyne, United Kingdom

Cerillo – Charlottesville, Virginia

CytoRecovery – Blacksburg, Virginia

EmGenisys – Houston

EpiPaws – Fort Lauderdale, Florida

FemtoFluidics – Excelsior, Minnesota

Life Magnetics – Ann Arbor, Michigan

Narwhal Bio – San Diego

Nyctea Technologies – Gothenburg, Sweden

Pluto Bio – Denver

Polybiomics – Berkeley, California and Seattle

QurCan Therapeutics – Toronto, Ontario and Cambridge, Massachusetts

React4Life – Genoa, Italy

Redbud Labs – Research Triangle Park, North Carolina

Ryght – Laguna Beach, California

Sarcura – Klosterneuburg, Austria

Syenex – Chicago

BioTools Innovator thanks our expert ecosystem including representatives from Agilent, Becton Dickinson, Biomedical Advanced Research and Development Authority (BARDA), Catalent Pharma Solutions, Danaher, Draper, Eppendorf, Foresite Labs, Genentech, General Inception, Genoa Ventures, Illumina Ventures, Johnson & Johnson Innovation, Northpond Ventures, PacBio, Qiagen, Thermo Fisher Scientific, Teknova, and VC23, among others for participating in this year’s program as mentors, judges and advisors.

Funding for BioTools Innovator is provided by the Frederick Gardner Cottrell Foundation of RCT. Additional support is provided by BroadOak Capital Partners and Nissan Chemical America Corporation.

“In React4Life, we are honored to be part of this selection and to have the opportunity to showcase our MIVO technology in the heart of Silicon Valley. Our innovative MIVO® organ on chip technology is revolutionizing preclinical testing across various research fields and aligns perfectly with the BioTools Innovator program.”

— Maurizio Aiello, CEO of React4Life

About BioTools Innovator

Based in Los Angeles, BioTools Innovator was established to advance cutting-edge research and improve human health by accelerating the growth of a broad spectrum of life science tools and diagnostics. BioTools Innovator matches industry leaders with innovative early stage and emerging growth biotechnology-focused companies for mentorship and support.

BioTools Innovator is powered by MedTech Innovator, the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry. To date, MedTech Innovator has supported 612 alumni that have gone on to raise over $8 billion in follow-on funding, brought 310 products to market, and achieved 45 exits.

For more information about BioTools Innovator, visit the website, and follow the organization on LinkedIn.

About React4life

React4Life is an Italian biotech company transforming the preclinical research landscape by successfully addressing challenges for hundreds of clients worldwide.
At the heart of React4Life lies our revolutionary MIVO® technology, backed by over two decades of dedicated academic research. We are pioneers in the development of MIVO®-based organ-on-chip systems, representing a breakthrough in microphysiological technology for faithfully recapitulating human biology in the lab.
MIVO® human on chip platform overcomes the limits of traditional in vitro assays and animal models. It improves the reliability and predictivity of several applications in the fields of drug testing, personalized medicine, immuno-oncology, dermocosmetics, and nutraceuticals.
At React4life, Italian creativity transforms biotech challenges into customized, cutting-edge solutions. Our worldwide clients’ feedback fuels our commitment to meeting their evolving needs.

Learn more at and follow us on LinkedIn.